In the following years, Vranová and colleagues (2014) confirmed higher CSF CLU levels in PD and PD with dementia patients when compared to controls [83], and in a later study, compared to other neurodegenerative diseases such as dementia with LBs, AD, progressive supranuclear palsy, and multiple system atrophy [84]. This evidence concerns the gene CLU and neurodegenerative disease.